e-learning
resources
Munich 2006
Sunday 03.09.2006
Pathogenic aspects of lung injury, destruction and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics
J. Liebhart, M. Polak, A. Dabrowski, R. Dobek, E. Liebhart, A. Dor, W. Barg, A. Kulczak, U. Gladysz, A. Lange (Wroclaw, Poland)
Source:
Annual Congress 2006 - Pathogenic aspects of lung injury, destruction and repair
Session:
Pathogenic aspects of lung injury, destruction and repair
Session type:
Thematic Poster Session
Number:
1155
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Liebhart, M. Polak, A. Dabrowski, R. Dobek, E. Liebhart, A. Dor, W. Barg, A. Kulczak, U. Gladysz, A. Lange (Wroclaw, Poland). Transforming growth factor-beta 1 (TGF-beta1) gene polymorphism in coincidence with some other host and environmental factors is associated with irreversible bronchoconstriction in asthmatics. Eur Respir J 2006; 28: Suppl. 50, 1155
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 92s
Year: 2001
Transforming growth factor-beta1 (TGF-beta1) gene polymorphism in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis
Source: Eur Respir J 2011; 37: 169-175
Year: 2011
Transforming growth factor beta (TGFβ)-2 and -3 gene polymorphisms in different phenotypes of sarcoidosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma
Source: Eur Respir J 2006; 27: 208-229
Year: 2006
Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Transforming growth factor beta 1 (TGF-ß1) level as a marker of COPD severity
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Transforming growth factor beta (TGF-ß) pathway activation by IPF fibroblast-derived soluble factors is mediated by IL-6 trans-signaling
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Transforming growth factor beta-1 gene polymorphisms and course of asthma
Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma
Year: 2011
Transforming growth factor (TGF)-b
1
gene common polymorphisms and plasma TGF-b
1
levels in patients with lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 435s
Year: 2005
Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Idiopathic pulmonary fibrosis in relation to the gene polymorphisms of transforming growth factor-beta1 and plasminogen activation inhibitor 1
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Nerve growth factor (NGF) gene polymorphism in allergic asthma
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Relationship between level of transforming growth factor beta 1 (TGF beta 1) and serum amyloid A in COPD patients
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Transforming growth factor-β
1
gene polymorphism and susceptibility to idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005
Insulin-like growth factor binding protein-3 induction by transforming growth factor-β1 mediates differentiation of a myofibroblast phenotype in human lung fibroblasts
Source: Eur Respir J 2003; 22: Suppl. 45, 7s
Year: 2003
A comparative study of two angiogenic factors: vascular endothelial growth factor (VEGF) and angiogenin (Ang) in induced sputum from asthmatic children in acute attack
Source: Eur Respir J 2006; 28: Suppl. 50, 258s
Year: 2006
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018
Year: 2018
Transforming growth factor alpha produces airway remodelling and reduces airway distensibility
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept